12 April 2024
The Evers company has registered a new medical product: an ointment mesh sterile dressing for wound healing. Production of this product has already commenced at the company’s facility, with a staggering target of manufacturing 40,000 units monthly.
As specified, investments in the project amounted to 11 million rubles. The bandage is an atraumatic rectangular polyester mesh impregnated with a medicinal ointment composition. It is based on copper and zinc. The mesh is designed to fit any complex wound, without adhering to the wound surface and without causing any discomfort when removed or replaced. It is noted that the ointment base of the dressing prevents the entry of microorganisms.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024